| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.27 | 0.04 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |